Balance sheet of Brooks Laboratories is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Brooks Laboratories is increasing.
Latest net debt of Brooks Laboratories is ₹4.82 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹3.68 Crs.

Yes, profit is increasing.
The profit of Brooks Laboratories is ₹2.78 Crs for TTM, -₹19.59 Crs for Mar 2024 and -₹20.89 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Brooks Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances